Cargando…
In Vitro and In Vivo Activity of Zabofloxacin and Other Fluoroquinolones Against MRSA Isolates from A University Hospital in Egypt
The widespread of infections caused by methicillin-resistant Staphylococcus aureus (MRSA), has necessitated the search for alternative therapies; introduction of new agents being a suggestion. This study compares the in vitro and in vivo activities of zabofloxacin, a novel fluoroquinolone, with moxi...
Autores principales: | MOHAMED, NELLY M., ZAKARIA, AZZA S., EDWARD, EVA A., ABDEL-BARY, AMANY |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Exeley Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256792/ https://www.ncbi.nlm.nih.gov/pubmed/31050254 http://dx.doi.org/10.21307/pjm-2019-007 |
Ejemplares similares
-
Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline
por: Kocsis, Béla, et al.
Publicado: (2021) -
Association between fluoroquinolone resistance and MRSA genotype in Alexandria, Egypt
por: Alseqely, Mustafa, et al.
Publicado: (2021) -
Antimicrobial Activity of Zabofloxacin against Clinically Isolated Streptococcus pneumoniae
por: Park, Hee-Soo, et al.
Publicado: (2016) -
Resensitization of Fluconazole-Resistant Urinary Candida spp. Isolates by Amikacin through Downregulation of Efflux Pump Genes
por: EDWARD, EVA A., et al.
Publicado: (2020) -
Pathogenicity Islands in Uropathogenic Escherichia coli Clinical Isolate of the Globally Disseminated O25:H4-ST131 Pandemic Clonal Lineage: First Report from Egypt
por: Zakaria, Azza S., et al.
Publicado: (2022)